LDN Low Dose Naltrexone 4.5mg

Low Dose Naltrexone (LDN) 4.5 mg Capsules

Product Description:

LDN 4.5 mg Capsules are a low-dose formulation of Naltrexone, designed for therapeutic use in conditions involving immune dysregulation, chronic inflammation, and neuropathic pain. This dose is commonly used as a maintenance level after titration from 1.5 mg or 3 mg.

Originally approved for opioid and alcohol dependence in higher doses (50 mg), Naltrexone at low doses has shown promise in off-label use for autoimmune disorders, neuroinflammatory diseases, and chronic pain syndromes. The 4.5 mg strength is one of the most commonly used doses among LDN regimens.

Common Off-Label Uses:

• Multiple Sclerosis (MS)

• Crohn’s Disease

• Hashimoto’s Thyroiditis

• Fibromyalgia

• Rheumatoid Arthritis

• Chronic Fatigue Syndrome (CFS)

• Psoriasis and eczema

• Endometriosis

• Interstitial cystitis

• Complex regional pain syndrome (CRPS)

Mechanism of Action:

At 4.5 mg, Naltrexone briefly blocks opioid receptors, leading to a compensatory increase in endorphins and enkephalins. These natural opioids are thought to help balance the immune system, reduce inflammation, and relieve pain and fatigue in chronic conditions.

Key Features:

• Standard 4.5 mg strength, widely used in LDN therapy

• Supplied in strip packs of 10 capsules

• Smooth transition for patients titrated up from 1.5 or 3 mg

• Manufactured under GMP-certified conditions

• Used globally in integrative and functional medicine